Close Menu
    What's Hot

    Royal Horticultural Society 1974 Pension Scheme Completes Bulk Purchase Annuity Transaction With Royal London

    August 17, 2026

    Athora To Sell German Business to Frankfurter Leben

    August 17, 2026

    The Royal Society of Chemistry Pension Scheme Completes Bulk Purchase Annuity Buy-in With PIC

    August 13, 2026
    X (Twitter) LinkedIn
    Longevity & Mortality Investor
    • Home
    • Coverage
      1. Life Insurance Capital Solutions
      2. Life Insurance
      3. Longevity and Mortality Risk Transfer
      4. Mortality
      5. Secondary Life Markets
      6. View All

      Royal Horticultural Society 1974 Pension Scheme Completes Bulk Purchase Annuity Transaction With Royal London

      August 17, 2026

      Athora To Sell German Business to Frankfurter Leben

      August 17, 2026

      Talcott Financial Group, Goldman Sachs Launch West Grove Re

      August 5, 2026

      Lincoln Financial Reinsures Universal Life Block With Talcott

      August 3, 2026

      US Individual Life Insurance Sales Continue Growth Trend in the Second Quarter

      August 13, 2026

      Shaping the Future of Health Insurance Through Innovation and Analytics

      June 10, 2026

      Q&A: Dr Christoph Schmitt, Director, Insurance, Fitch Ratings

      May 28, 2026

      Chronic Disease Onset and Cumulative Exposure: Clinical, Prognostic and Underwriting Implications

      May 13, 2026

      US Life Carriers Eyeing VM-22 for a Pension Risk Transfer Pricing Advantage in 2027

      August 12, 2026

      Elementis Group Pension Scheme Completes Bulk Purchase Annuity Buy-In With Aviva

      August 5, 2026

      Hickson UK Group Pension Scheme Completes Bulk Purchase Annuity Transaction With Royal London

      August 3, 2026

      UK Insurance Company Pension Scheme Completes Bulk Purchase Annuity Transaction With M&G

      August 3, 2026

      Record Low Mortality Rates So Far in England and Wales in 2026

      July 9, 2026

      Organ Transplant Improvements Test Life Expectancy Assessment Models

      July 8, 2026

      The Pursuit of Everlasting Life Unlikely to Shift Actuarial Models

      June 10, 2026

      Pricing in the Unknown: Why Mortality Models Aren’t Ready for MCED Tests Just Yet

      April 9, 2026

      The Royal Society of Chemistry Pension Scheme Completes Bulk Purchase Annuity Buy-in With PIC

      August 13, 2026

      New Life Settlement Provider Data Illustrates Continued Evolution of Secondary Life Settlement Market

      August 12, 2026

      The Crucial Role of Regular Medical Record Reviews in Life Settlement Investments

      August 12, 2026

      Corry Capital Advisors Adds John Daniel as Senior Director of Analytics and AI Strategy

      August 6, 2026

      Royal Horticultural Society 1974 Pension Scheme Completes Bulk Purchase Annuity Transaction With Royal London

      August 17, 2026

      Athora To Sell German Business to Frankfurter Leben

      August 17, 2026

      The Royal Society of Chemistry Pension Scheme Completes Bulk Purchase Annuity Buy-in With PIC

      August 13, 2026

      US Individual Life Insurance Sales Continue Growth Trend in the Second Quarter

      August 13, 2026
    • Events
    • Latest Issues

      Editor’s Letter – Volume 2, Issue 8, August 2026

      August 12, 2026

      Editor’s Letter – Volume 2, Issue 7, July 2026

      July 8, 2026

      Editor’s Letter – Volume 2, Issue 6, June 2026

      June 10, 2026

      Editor’s Letter – Volume 2, Issue 5, May 2026

      May 13, 2026

      Editor’s Letter – Volume 2, Issue 4, April 2026

      April 9, 2026
    • Contact Us
    Newsletter
    Longevity & Mortality Investor

    The Power of Uncorrelated Diversification During Market Volatility

    Secondary Life Markets May 14, 2025By Jay Jackson
    Share
    Twitter LinkedIn Email

    In volatile financial environments, institutional and retail investors increasingly seek asset classes untethered to the whims of global markets. The wild first quarter of 2025 has reinforced the market’s inherent potential for unpredictability, further underscoring the importance of uncorrelated investment vehicles.  

    Lifespan-based financial products, when tied to sophisticated longevity analysis and advanced actuarial technology, have emerged as an alternative asset class that provides substantial liquidity for individual life insurance policyholders and uncorrelated returns for investors, regardless of market cycles. 

    Countercyclical Returns Through Actuarial Science 

    Lifespan-based financial products are rooted in the analysis of longevity data, which, when approached correctly, can produce incredibly accurate and predictable outcomes, primarily through investment in individual life insurance policies. 

    For investors, the fundamental value proposition of lifespan-based financial products is simple: they have near-zero correlation to traditional market indices and the often-chaotic impulses of global markets. While equity markets can be volatile and fixed-income securities respond to interest rate fluctuations, the value of lifespan-based products is governed strictly by actuarial mathematics fed by decades of hard data and sample sizes in the tens of millions rather than short-term market sentiment or economic cycles.  

    In short, the data analysis on whether or not to invest in owning a life insurance policy from a 72-year-old male after reviewing all medical data and aligning it with historical medical outcomes is unpolluted by national or global economic trends. The analysis and expected returns are effectively the same regardless of market conditions. 

    In decades spent building lifespan-based products, primarily analyzing, purchasing, and selling life insurance policies, we’ve seen time and again how market uncertainty prompts individuals and financial advisors to seek alternative liquidity sources. Investing in these types of assets provides a countercyclical advantage, offering consistent, mathematically predictable returns insulated from market disruptions. 

    Monetizing Insurance Assets: A Significant Liquidity Event 

    For individuals approaching or at retirement age, the prevailing economic conditions have validated the need to explore better utilization of life insurance assets to achieve financial security.  

    While historically overlooked as a financial asset and tool, over the past twenty years, life insurance has become increasingly recognized by policyholders and investors as an asset that can be strategically leveraged during a lifetime, not only for claims paid after a person passes.  

    There is an estimated $13.2 trillion dollars locked up in life insurance policies in the US today – 2.5 times the size of the residential real estate market. Whether term or whole life, these policies are an asset owned by the buyer, not the insurance company, meaning the policyholder can sell the policy, like a home or other assets. 

    However, this asset class is not utilized in the same way as other traditional assets by far too many retirees. More than 90% of life insurance policies lapse, and a claim is never paid, so the vast majority of people pay into an asset — and never realize their investment.  

    By paying a price significantly over the cash surrender value of a life insurance policy, we can create a predictable and highly beneficial financial transaction to increase liquidity and give retirees more options, regardless of economic conditions or market trends.  

    Selling an insurance policy can create the liquidity needed to meet capital requirements, optimize retirement planning, or establish financial reserves. With an influx of cash, individuals can help insulate themselves from the market volatility affecting their investment portfolios.  

    Fundamentally, selling a life insurance policy allows individuals to convert an otherwise illiquid asset into deployable capital, enhancing financial flexibility when traditional investment markets may demonstrate heightened uncertainty. 

    Strategic Positioning and Market Outlook 

    As market volatility ebbs and flows, selling a life insurance policy can help policyholders maximize the liquidity of their life insurance assets while simultaneously creating uncorrelated portfolio opportunities for investors. 

    In an investment landscape characterized by increasing correlation across traditional asset classes, lifespan-based products represent a unique opportunity derived from actuarial mathematics rather than unpredictable economic winds.  

    Jay Jackson is Chairman and Chief Executive Officer of Abacus Global Management 


    Any views expressed in this article are those of the author(s) and may not necessarily represent those of Life Risk News or its publisher, the European Life Settlement Association

    2025 - May Commentary Life Settlements Longevity Risk Volume 4 Issue 5 - May 2025
    Share. Twitter LinkedIn Email

    Related Posts

    The Royal Society of Chemistry Pension Scheme Completes Bulk Purchase Annuity Buy-in With PIC

    August 13, 2026By LMI Newsdesk

    New Life Settlement Provider Data Illustrates Continued Evolution of Secondary Life Settlement Market

    August 12, 2026By Greg Winterton

    The Crucial Role of Regular Medical Record Reviews in Life Settlement Investments

    August 12, 2026By Fergus Bescoby

    Corry Capital Advisors Adds John Daniel as Senior Director of Analytics and AI Strategy

    August 6, 2026By LMI Newsdesk
    Latest Issue

    New Life Settlement Provider Data Illustrates Continued Evolution of Secondary Life Settlement Market

    August 12, 2026

    The Crucial Role of Regular Medical Record Reviews in Life Settlement Investments

    August 12, 2026

    US Life Carriers Eyeing VM-22 for a Pension Risk Transfer Pricing Advantage in 2027

    August 12, 2026

    End-Game Clarity Shaping UK Pension Risk Transfer Market but Large Schemes Still on the Sidelines

    July 22, 2026
    Ad

    Where Longevity and Mortality Meet the Markets
    ISSN 2978-5219

    X (Twitter) LinkedIn
    Coverage
    • Life Insurance Capital Solutions
    • Life Insurance
    • Longevity and Mortality Risk Transfer
    • Mortality Risk
    • Secondary Life Markets
    More Info
    • Home
    • About Us
    • Contact Us
    • Guest Articles
    • Submit Story Idea
    Our Newsletter
    Get the latest industry news, commentary and events from the Longevity & Mortality Investor directly into your inbox. Why not sign up today?

    © 2026 Longevity & Mortality Investor. Website by Kavells.
    • Sitemap
    • Privacy Policy
    • Copyright Notice
    • Terms & Conditions

    Type above and press Enter to search. Press Esc to cancel.